SKI Market

Indian Indices

Sensex

83,878.17 301.93
( 0.36%)

Global Indices

Nasdaq

49,520.87 233.75
(0.47%)

Dow Jones

6,986.78 44.32
(0.64%)

Hang Seng

51,918.01 800.75
(1.57%)

Nikkei 225

10,139.59 14.99
(0.15%)

Forex

USD-INR

89.91 -0.02
(-0.02%)

EUR-INR

104.90 -0.20
(-0.19%)

GBP-INR

120.86 -0.43
(-0.35%)

JPY-INR

0.57 0.00
(-0.15%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Concord Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543960

INE338H01029

174.4719509

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CONCORDBIO

42.98

13817.71

EPS(TTM)

Face Value()

Div & Yield %

30.73

0.66

Back

Fedders Holding consolidated net profit declines 18.31% in the June 2025 quarter

Aug 15,2025

Net profit of Fedders Holding declined 18.31% to Rs 16.46 crore in the quarter ended June 2025 as against Rs 20.15 crore during the previous quarter ended June 2024. Sales declined 45.50% to Rs 77.40 crore in the quarter ended June 2025 as against Rs 142.01 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	77.40	142.01	-45
OPM %	10.13	12.75	-
PBDT	14.02	22.14	-37
PBT	13.03	21.46	-39
NP	16.46	20.15	-18

83,878.17 301.93 ( 0.36%)

49,520.87 233.75 (0.47%)

6,986.78 44.32 (0.64%)

51,918.01 800.75 (1.57%)

10,139.59 14.99 (0.15%)

89.91 -0.02 (-0.02%)

104.90 -0.20 (-0.19%)

120.86 -0.43 (-0.35%)

0.57 0.00 (-0.15%)